PRE-MRNA SPLICE SITE RECOGNITION IN HUMAN DISEASE

人类疾病中的前 mRNA 剪接位点识别

• 批准号: 8171502
• 负责人: CLARA KIELKOPF
• 金额: $ 0.54万
• 依托单位: CORNELL UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-07-01 至 2011-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8171502
• 关键词: Binding; Cells; Complex; Computer Retrieval of Information on Scientific Projects Database; Consensus Sequence; Cytosine; Data Set; Disease; Foundations; Funding; Goals; Grant; Housing; Human; Inherited; Institution; Molecular Conformation; Nucleic Acids; Nucleotides; Oligonucleotides; Positioning Attribute; RNA; RNA Sequences; RNA Splicing; Recruitment Activity; Research; Research Personnel; Resolution; Resources; Shapes; Site; Source; Staging; Structure; United States National Institutes of Health; Uracil; Uridine; Work; human disease; in vivo; mRNA Precursor; synchrotron radiation

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The overall goal of our research is to understand the three-dimensional shapes that guide interaction of pre-mRNA splicing factors with the 3¿¿" splice site, thereby providing a foundation to develop treatments for inherited diseases associated with errors in splice site recognition. The essential human splicing factor, U2AF binds to the pre-mRNA 3¿¿" splice site consensus sequence during the critical early stages of splice site choice, and recruits the core splicing machinery. We recently determined the structure of U2AF in complex with poly-uridine with the aid of synchrotron radiation [Sickmier et al. (2006) Mol. Cell). This structure demonstrates the mechanism of uridine recognition by U2AF. However, the in vivo RNA targets of U2AF contain cytosine. The goal of the proposed work is to understand how U2AF changes conformation to recognize a cytosine instead of uracil. To this end we have crystallized U2AF with three different uridine-rich oligonucleotides with single-positions changed to cytosine. Specific nucleotides are brominated to unambiguously identify the nucleic acid register. Cocrystals with one of the sequences diffract to 2.9¿ resolution, and two other cocrystals diffract to better than 3.5¿ resolution in-house. Synchrotron radiation is required to obtain the high resolution data sets to reveal subtle conformational changes of this essential splicing factor bound to target RNA sequences.

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 我们研究的总体目标是了解引导前mRNA剪接因子与3”剪接位点相互作用的三维形状，从而为开发与剪接位点识别错误相关的遗传性疾病的治疗方法提供基础。人类必需的剪接因子U2 AF在剪接位点选择的关键早期阶段与前mRNA 3”剪接位点共有序列结合，并募集核心剪接机制。我们最近借助于同步加速器辐射确定了与聚尿苷复合的U2 AF的结构[Sicklett等人（2006）Mol. Cell）。 该结构证明了U2 AF识别尿苷的机制。 然而，U2 AF的体内RNA靶标含有胞嘧啶。拟议工作的目标是了解U2 AF如何改变构象以识别胞嘧啶而不是尿嘧啶。为此，我们用三种不同的富含尿苷的寡核苷酸将U2 AF结晶，其中单个位置改变为胞嘧啶。特定的核苷酸被溴化以明确地识别核酸寄存器。具有其中一个序列的共晶在内部衍射至2.9 º分辨率，而另外两个共晶在内部衍射至优于3.5 º分辨率。需要同步辐射来获得高分辨率的数据集，以揭示这种与靶RNA序列结合的必需剪接因子的细微构象变化。